PLoS Pathogens (Nov 2019)

The ETS transcription factor ELF1 regulates a broadly antiviral program distinct from the type I interferon response.

  • Leon Louis Seifert,
  • Clara Si,
  • Debjani Saha,
  • Mohammad Sadic,
  • Maren de Vries,
  • Sarah Ballentine,
  • Aaron Briley,
  • Guojun Wang,
  • Ana M Valero-Jimenez,
  • Adil Mohamed,
  • Uwe Schaefer,
  • Hong M Moulton,
  • Adolfo García-Sastre,
  • Shashank Tripathi,
  • Brad R Rosenberg,
  • Meike Dittmann

DOI
https://doi.org/10.1371/journal.ppat.1007634
Journal volume & issue
Vol. 15, no. 11
p. e1007634

Abstract

Read online

Induction of vast transcriptional programs is a central event of innate host responses to viral infections. Here we report a transcriptional program with potent antiviral activity, driven by E74-like ETS transcription factor 1 (ELF1). Using microscopy to quantify viral infection over time, we found that ELF1 inhibits eight diverse RNA and DNA viruses after multi-cycle replication. Elf1 deficiency results in enhanced susceptibility to influenza A virus infections in mice. ELF1 does not feed-forward to induce interferons, and ELF1's antiviral effect is not abolished by the absence of STAT1 or by inhibition of JAK phosphorylation. Accordingly, comparative expression analyses by RNA-seq revealed that the ELF1 transcriptional program is distinct from interferon signatures. Thus, ELF1 provides an additional layer of the innate host response, independent from the action of type I interferons.